More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-13 of 13 results

  • amyriadtherapeutics.com
  • 1
  • 7
AMYRI AD is committed to modernizing current techniques for staging AD severity and assessing the impact of drug treatments. We are partnering with experts in digital technologies to transform 20th-century instruments for 21st-century patients... AD..

Relevance: 15.647393
  • www.admit-therapeutics.com
  • 1
  • 9
ADmit THERAPEUTICS - test for an early AD detection. Alzheimer's disease. DETECTION IN CLINICAL PRACTICE. ADmit Therapeutics, S.L. is a company focused on the development and commercialization of a novel Alzheimer's disease (AD) early detection..

Relevance: 15.275377
  • www.retispec.com
  • 1
  • 19
RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye... RetiSpec believes a better future for Alzheimer's starts with the ability to diagnose it. Our mission..

Relevance: 10.735965
  • www.dolbyventures.com
  • 1
  • 1
  • 16
Dolby Family Ventures is an early stage venture firm focused on building great technology companies. We partner with best-in-class innovators and strong investment syndicate partners at the seed stage of a company's development... Dolby Family..

Relevance: 10.38823
  • www.pinteon.com
  • 1
  • 19
We aim to maintain brain health in patients with brain injury and neurodegenerative diseases by interrupting the spread of toxic tau...

Relevance: 9.915137
  • www.worlddementiacouncil.org
  • 3
  • 27
The World Dementia Council (WDC) is an international charity. It consists of senior experts and leaders drawn from research, academia, industry, governments and NGOs in both high-income and low- and middle-income countries, including two leaders with..

Relevance: 8.968982
  • www.oryzon.com
  • 2
  • 3
  • 19
ORYZON is a public clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology... ORYZON is a clinical..

Relevance: 8.725379
  • globalalzplatform.org
  • 1
  • 30
million Americans are living with Alzheimer's disease, over 16 million Americans actively support their care... was the year the last therapy approved for modestly addressing Alzheimer's disease was developed. There are no disease-modifying..

Relevance: 6.8509207
  • globalalzplatform.org
  • 2
  • 62
The Global Alzheimer's Platform Foundation (GAP) is a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those living with Alzheimer's and Parkinson's by reducing the time and cost of Alzheimer's..

Relevance: 4.121505
  • www.alzdiscovery.org
  • 2
  • 1
  • 68
The ADDF focuses on translating the knowledge we have gained about the causes of Alzheimer's disease - known as the "biology of aging" - into drugs to conquer it. We support diverse projects focused on novel targets that hold great promise, but also..

Relevance: 3.5549812
  • www.alzdiscovery.org
  • 2
  • 1
  • 68
Make smarter brain health choices with Cognitive Vitality. ADDF scientists evaluate the science and rate food, drink, drugs, vitamins, and supplements based on their potential benefits for dementia prevention... The ADDF focuses on translating the..

Relevance: 3.5549812
  • mountsaintvincent.edu
  • 25
  • 10
  • 152
The New York Times features CMSV as one of the country's most selective colleges for economic diversity... Welcome to the Right Place on the River! Get started on defining and achieving your dreams at the University of Mount Saint Vincent...

Relevance: 1.5176227
  • mountsaintvincent.edu
  • 25
  • 10
  • 152
At Mount Saint Vincent, a student's education extends beyond knowledge, skills, and preparation for work. We seek the development of the whole person. In the spirit of Vincent de Paul and Elizabeth Ann Seton, we foster an understanding of our common..

Relevance: 1.4905027